Pages Tagged with "Don J Diamond"

Celebrating ‘everyday heroes’ during hospital week
National Hospital Week is an opportunity to highlight hospitals, health systems and health care workers and the innovative ways they are supporting and connected to patients and the community. As...
New preclinical data show broad immune response to City of Hope-developed COVID-19 vaccine
  Don J. Diamond, Ph.D. COH04S1, a City of Hope-developed COVID-19 investigational vaccine, stimulated broad-spectrum protective immunity against SARS-CoV-2 variants in new preclinical research due to its inclusion of both...
City of Hope scientists delving into COVID-19 research
As City of Hope’s research to find better treatments for cancer and diabetes continues during the COVID-19 pandemic, the institution’s renowned physician-scientists are also using their expertise to attack the deadly...
Selflessness and courage during an extraordinary time
The year 2020 and its aftermath shook the world. But City of Hope faced the difficulties of the coronavirus outbreak while staying focused on its mission — and even building momentum —...
Phase 2 Trial Opens for City of Hope's Novel COVID-19 Vaccine
City of Hope is now enrolling patients in a Phase 2 clinical trial of its COH04S1 vaccine, which is the first to study the safety and effectiveness of an investigational...
City of Hope Enters Commercial License Agreement to Use ProBioGen’s AGE1.CR® Vaccine Manufacturing Platform
CONTACT Letisia Marquez 626-476-7593lemarquez@coh.org   DUARTE, Calif. — ProBioGen AG has announced a commercial product license agreement with City of Hope®, a world-renowned independent research and treatment center for...
City of Hope COVID-19 vaccine shows effectiveness in Phase 1 trial
A COVID-19 investigational vaccine developed by City of Hope scientists and now licensed to GeoVax Labs Inc. produced a robust neutralizing antibody and T cell (an immune cell) response against...
City of Hope initiates phase 1 clinical trial to test its first SARS-CoV-2 investigational vaccine
CONTACT Letisia Marquez 626-476-7593lemarquez@coh.org   •    The vaccine strategy used to generate this candidate has a record of safety and efficacy, rapid immune response and lasting protection   •  ...
Data published in a Lancet journal on COH04S1, a City of Hope-developed COVID-19 vaccine, shows it produced robust antibodies and T cells against SARS-CoV-2
MEDIA CONTACT Letisia Marquez 626-218-3398lemarquez@coh.org The investigational vaccine is now being used in Phase 2 trials for immunocompromised patients and as a booster for healthy adult volunteers.   LOS...
GeoVax and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine
Contacts: Letisia Marquez City of Hope Media Relations Manager lemarquez@coh.org 626-476-7593   GeoVax Labs, Inc. investor@geovax.com 678-384-7220   Phase 2 Vaccine Designed to Enhance Response for Immunocompromised Patients Complements GeoVax’s...
Subscribe to Don J Diamond